HBM9014

N/A

Report date: 2023/02/27 14:53:18

Base Information

Drug NameHBM9014
Drug Alias NameHBM-9014
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionLeukemia inhibitory factor receptor antagonists
TargetsLeukemia inhibitory factor receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHarbour Biomed
China Registration ClassN/A

Develop Information

Active CompaniesHarbour Biomed
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A